bevacizumab,trifluridine tipiracil
roche,otsuka,taiho pharma
[]
results of the sunlight study #gi23 for 3rd line therapy in colorectal cancer using longsurf &amp; bevacizumab demonstrated superior os, pfs compared to ftp/tpi alone. no response differences based on kras mutation status or tumor location #colorectalcancer 
Gastrointestinal Oncologist, Physician Scientist & Mother CMO PanOncology Trials. Tweets are mine.